The total return over the past 12 months is -64.35% vs. +16.94% for the S&P 500. So far it's up -49.03% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (64.35%) | (55.03%) | (52.92%) | (42.38%) | N/A | N/A |
| Total Return CAGR | (64.35%) | (55.03%) | (52.92%) | (42.38%) | N/A | N/A |
| Revenue CAGR | (22.65%) | (7.61%) | +10.10% | +27.72% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
DarioHealth Corp. (DRIO)
| Year | Start price | End price | DRIO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.38 | $5.80 | (49.03%) | +14.51% | (63.54%) |
| 2025 | $15.72 | $11.38 | (27.61%) | +17.72% | (45.33%) |
| 2024 | $34.40 | $15.72 | (54.30%) | +24.89% | (79.19%) |
| 2023 | $85.60 | $34.40 | (59.81%) | +26.19% | (86.00%) |
| 2022 | $259.40 | $85.60 | (67.00%) | (18.17%) | (48.83%) |
| 2021 | $285.80 | $259.40 | (9.24%) | +28.74% | (37.98%) |
| 2020 | $131.20 | $285.80 | +117.84% | +18.37% | +99.47% |
| 2019 | $310.40 | $131.20 | (57.73%) | +31.22% | (88.95%) |
| 2018 | $640.80 | $310.40 | (51.56%) | (4.56%) | (47.00%) |
| 2017 | $1,300.00 | $640.80 | (50.71%) | +21.70% | (72.41%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
